Tech Company Financing Transactions
Iantrek Funding Round
On 8/20/2025, Iantrek raised $42 million in Series C financing from U.S. Venture Partners, aMoon Fund and Civilization Ventures.
Transaction Overview
Company Name
Announced On
8/20/2025
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series C
Investors
U.S. Venture Partners (Lead Investor)
Sectoral Asset Management (Marc Marcotle)
Visionary Venture Fund (Farrell Tyson)
Proceeds Purpose
The company intends to use the funds for the U.S. commercial launch of AlloFlo� Uveo, a surgical solution targeting the uveoscleral pathway, as well as broader pipeline expansion.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
151 E Post Rd 110-111
White Plains, NY 10601
USA
White Plains, NY 10601
USA
Phone
Website
Email Address
Overview
Developer of a minimally invasive technology designed to offer ophthalmic medical devices. The company offers advanced micro-interventional surgical technologies, enabling clients to go through eye surgery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Ianchulev
Chief Financial Officer
Michael Haydin
Chief Operating Officer
David Robson
Browse more venture capital transactions:
Prev: 8/20/2025: Upstage venture capital transaction
Next: 8/20/2025: Zed Industries venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs